Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine

The two currently available ten- and thirteen-valent pneumococcal conjugate vaccines (PCV10 and PCV13) both induce serotype-specific IgG anti-polysaccharide antibodies and are effective in preventing vaccine serotype induced invasive pneumococcal disease (IPD) as well as in reducing overall vaccine-...

Descripción completa

Detalles Bibliográficos
Autores principales: van Westen, Els, Knol, Mirjam J., Wijmenga-Monsuur, Alienke J., Tcherniaeva, Irina, Schouls, Leo M., Sanders, Elisabeth A. M., van Els, Cecile A. C. M., Berbers, Guy A. M., Rots, Nynke Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313931/
https://www.ncbi.nlm.nih.gov/pubmed/30544898
http://dx.doi.org/10.3390/vaccines6040082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313931/
https://www.ncbi.nlm.nih.gov/pubmed/30544898
http://dx.doi.org/10.3390/vaccines6040082

Ejemplares similares